Literature DB >> 30251060

TEKT4 Promotes Papillary Thyroid Cancer Cell Proliferation, Colony Formation, and Metastasis through Activating PI3K/Akt Pathway.

Zhouci Zheng1, Xiaofen Zhou2, Yefeng Cai2, Endong Chen2, Xiaohua Zhang2, Ouchen Wang2, Qingxuan Wang3, Haiguang Liu4.   

Abstract

Thyroid carcinoma is the most common malignancy of the endocrine system worldwide, but its molecular mechanisms remain unclear. Some diseases are associated with TEKT4 gene. However, its role in thyroid carcinoma has yet to be fully examined. This study was designed to investigate the function of TEKT4 in papillary thyroid cancer (PTC). The effect of TEKT4 on aggressive behavior of PTC cell lines, namely, TPC1 and BCPAP, transfected with small interfering RNA was identified through cell proliferation, colony formation, migration, and invasion. Our previous study revealed that TEKT4 may be vital in PTC. In in vitro experiments, TEKT4 downregulation suppressed cell proliferation, colony formation, cell migration, and invasion. Our data also indicated that tumor-suppressing role of TEKT4 knockdown in PTC cell lines was associated with the silence of the PI3K/Akt pathway. Our study revealed that TEKT4 shows important biological implications and is worthy of further study.

Entities:  

Keywords:  Metastasis; PI3K/Akt pathway; Papillary thyroid cancer; TEKT4

Mesh:

Substances:

Year:  2018        PMID: 30251060     DOI: 10.1007/s12022-018-9549-0

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  16 in total

1.  [Expression of TEKT4 protein decreases in the ejaculated spermatozoa of idiopathic asthenozoospermic men].

Authors:  Wen-Bin Wu; Yu-Shan Li; Xiao-Fei Ji; Quan-Xian Wang; Xue-Min Gao; Xian-Feng Yang; Zhou-Hui Pan; Xiao-Xia Feng
Journal:  Zhonghua Nan Ke Xue       Date:  2012-06

2.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Authors:  Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian
Journal:  Cancer Res       Date:  2014-06-01       Impact factor: 12.701

Review 3.  Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

4.  Absence of tektin 4 causes asthenozoospermia and subfertility in male mice.

Authors:  Angshumoy Roy; Yi-Nan Lin; Julio E Agno; Francesco J DeMayo; Martin M Matzuk
Journal:  FASEB J       Date:  2007-01-23       Impact factor: 5.191

5.  Disease Severity at Presentation in Patients with Disease-Related Mortality from Differentiated Thyroid Cancer: Implications for the 2015 ATA Guidelines.

Authors:  Eyal Robenshtok; Yuval Nachalon; Carlos Benbassat; Dania Hirsch; Ilan Shimon; Alon Grossman; Talia Diker-Cohen; Amit Akirov; Aharon Popovtzer
Journal:  Thyroid       Date:  2017-09       Impact factor: 6.568

Review 6.  BRAF mutation in thyroid cancer.

Authors:  M Xing
Journal:  Endocr Relat Cancer       Date:  2005-06       Impact factor: 5.678

7.  Integrated genomic characterization of papillary thyroid carcinoma.

Authors: 
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

Review 8.  Molecular pathogenesis and mechanisms of thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Nat Rev Cancer       Date:  2013-03       Impact factor: 60.716

9.  Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.

Authors:  Zhi Liu; Peng Hou; Meiju Ji; Haixia Guan; Kimberly Studeman; Kirk Jensen; Vasily Vasko; Adel K El-Naggar; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2008-05-20       Impact factor: 5.958

Review 10.  The tektin family of microtubule-stabilizing proteins.

Authors:  Linda A Amos
Journal:  Genome Biol       Date:  2008-07-29       Impact factor: 13.583

View more
  8 in total

1.  Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor.

Authors:  Li-Ping Ge; Xi Jin; Yun-Song Yang; Xi-Yu Liu; Zhi-Ming Shao; Gen-Hong Di; Yi-Zhou Jiang
Journal:  Oncogene       Date:  2021-03-02       Impact factor: 9.867

2.  Clinicopathological characterization and prognostic implication of FOXP3 and CK19 expression in papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis.

Authors:  Salem Youssef Mohamed; Taiseer R Ibrahim; Samah S Elbasateeny; Lobna A Abdelaziz; Shaimaa Farouk; Mahmoud Abdou Yassin; Ahmed Embaby
Journal:  Sci Rep       Date:  2020-06-30       Impact factor: 4.379

3.  Identification of pivotal lncRNAs in papillary thyroid cancer using lncRNA-mRNA-miRNA ceRNA network analysis.

Authors:  Weiwei Liang; Fangfang Sun
Journal:  PeerJ       Date:  2019-09-19       Impact factor: 2.984

4.  BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.

Authors:  Cong Zhang; Chunrui Bo; Lunhua Guo; Pingyang Yu; Susheng Miao; Xin Gu
Journal:  World J Surg Oncol       Date:  2019-12-16       Impact factor: 2.754

5.  Identification of immune-related lncRNAs to improve the prognosis prediction for patients with papillary thyroid cancer.

Authors:  Zhiyang Li; Weixun Lin; Jiehua Zheng; Weida Hong; Juan Zou; Taofeng Zhang; Yexi Chen; Hai Lu
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

6.  The clinical significance of thyroid hormone-responsive in thyroid carcinoma and its potential regulatory pathway.

Authors:  Zhen-Xing Yu; Cheng Xiang; Sheng-Gui Xu; Yang-Ping Zhang
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

7.  Bioinformatics analysis to screen key genes in papillary thyroid carcinoma.

Authors:  Yuanhu Liu; Shuwei Gao; Yaqiong Jin; Yeran Yang; Jun Tai; Shengcai Wang; Hui Yang; Ping Chu; Shujing Han; Jie Lu; Xin Ni; Yongbo Yu; Yongli Guo
Journal:  Oncol Lett       Date:  2019-11-14       Impact factor: 2.967

Review 8.  Role of PI3K/AKT pathway in cancer: the framework of malignant behavior.

Authors:  Ningni Jiang; Qijie Dai; Xiaorui Su; Jianjiang Fu; Xuancheng Feng; Juan Peng
Journal:  Mol Biol Rep       Date:  2020-04-24       Impact factor: 2.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.